MedTrace Logo

HIgh Flow Versus NIV for Acute Cardiogenic PuLmonary Oedema With Acute Respiratory Failure in an ED

NCT04971213 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-01-06

No results posted yet for this study

Summary

The purpose of this study is to compare non invasive ventilation to high flow nasal cannula oxygen for the management of patients admitted with an acute respiratory failure due to an acute cardiogenic pulmonary edema.

Conditions

  • Cardiogenic Pulmonary Edema

Interventions

DEVICE

Non invasive ventilation

Emergency and transport ventilator (Monnal T60, Airliquide, Antony, France)

DEVICE

High-flow nasal cannula heated and humidified oxygen

AirVO2 device (Fisher and Paykel, New Zealand)

Sponsors & Collaborators

  • Poitiers University Hospital

    lead OTHER

Principal Investigators

  • Benjamin ALOS, MD · CHU Poitiers

  • Nicolas MARJANOVIC, MD PhD · CHU Poitiers

  • Jérémy Guenezan, MD · CH Nord-Vienne

  • Maxime Jonchier, MD · CHU de Poitiers (Site de Montmorillon)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-22
Primary Completion
2022-11-01
Completion
2022-12-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04971213 on ClinicalTrials.gov